Appointment of Broker

Cambridge, UK - 1st December 2017

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, is pleased to announce the appointment of Beaufort Securities Limited as the Company’s broker.

Download News

Back to all News